Search Our Scientific Publications & Authors

Dermatology 2021 Mar 2:1-8. Epub 2021 Mar 2.

Department of Dermatology, The First Affiliated Hospital of China Medical University, Shenyang, China,

Background/objective: Chronic skin disease (CSD) often has physiological, psychological, and social impacts, which requires the patient to adjust to achieve psychosocial adaptation (PSA). As a standardized assessment instrument was lacking, we developed a PSA questionnaire for patients with CSD (PSAQ-CSD).

Methods: According to the steps of questionnaire development, a systematic process of scoping review, qualitative research, content validity expert review, testing in a sample of 321 adults, item analysis, and classical test theory methods were applied. Read More

Mult Scler Relat Disord 2021 Feb 19;50:102772. Epub 2021 Feb 19.

PhD, Coordination of Clinical Research - National Cancer Institute - INCA, Rio de Janeiro, RJ, Brazil.

Background: Oropharyngeal dysphagia is a common symptom of many neurological diseases, including Multiple Sclerosis (MS). Early identification of the risk of dysphagia in neurological patients is very important for early referral for specialized evaluations of oropharyngeal swallowing and treatments. The Dysphagia in Multiple Sclerosis (DYMUS) questionnaire has been translated and validated in different countries over the last 10 years. Read More

J Pain Symptom Manage 2021 Feb 27. Epub 2021 Feb 27.

School of Medicine, Deakin University, Geelong, VIC 3220, Australia; Palliative Care, Barwon Health, Geelong, VIC 3220, Australia. Electronic address:

Background: Cancer cachexia negatively affects quality of life (QoL) and increases symptom burden. A multimodal treatment approach may optimise cachexia outcomes, including QoL. We evaluated QoL and symptoms over time among patients attending a multidisciplinary clinical service for cancer cachexia. Read More

Disabil Rehabil 2021 Mar 2:1-9. Epub 2021 Mar 2.

Department of Paediatrics,University of Melbourne, Parkville, Australia.

Purpose: To report initial psychometric evidence on the Measure of Early Vision Use.

Method: Data on performance of the Measure of Early Vision Use scale were collected from 100 parents of children with cerebral palsy aged 0-12 years online survey. Psychometric evaluation included assessment of scale dimensionality using Classical Test Theory and hypothesis testing for evidence of construct validity. Read More

BioDrugs 2021 Mar 2. Epub 2021 Mar 2.

Department of Rheumatology and Internal Medicine, Wrocław Medical University, Wrocław, Poland.

Background: SDZ-ADL (GP2017; Sandoz GmbH, Austria) is an EMA-/FDA-approved adalimumab biosimilar. The effect of SDZ-ADL on quality of life (QoL) and patient-reported outcomes (PROs) was assessed as part of two phase III studies, one in patients with moderate-to-severe chronic plaque psoriasis (PsO; ADACCESS) and the other in patients with rheumatoid arthritis (RA; ADMYRA). Additionally, ADACCESS included patients with psoriatic arthritis (PsA). Read More